Gerald E. Hancock

1.6k total citations
30 papers, 1.4k citations indexed

About

Gerald E. Hancock is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Gerald E. Hancock has authored 30 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Epidemiology, 14 papers in Infectious Diseases and 9 papers in Immunology. Recurrent topics in Gerald E. Hancock's work include Respiratory viral infections research (17 papers), Viral gastroenteritis research and epidemiology (7 papers) and Neonatal Respiratory Health Research (6 papers). Gerald E. Hancock is often cited by papers focused on Respiratory viral infections research (17 papers), Viral gastroenteritis research and epidemiology (7 papers) and Neonatal Respiratory Health Research (6 papers). Gerald E. Hancock collaborates with scholars based in United States, Ethiopia and Estonia. Gerald E. Hancock's co-authors include Gilla Kaplan, Zanvil A. Cohn, Andrew D. Luster, Paul W. Tebbey, Jason D. Smith, Michael Hagen, Dan J. Speelman, Cristina Cosco, Russell W. Schaedler and Thomas T. MacDonald and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and Journal of Virology.

In The Last Decade

Gerald E. Hancock

30 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerald E. Hancock United States 18 746 546 443 257 149 30 1.4k
D Kumararatne United Kingdom 15 469 0.6× 637 1.2× 410 0.9× 104 0.4× 69 0.5× 28 1.1k
Valeria Falcone Germany 22 850 1.1× 492 0.9× 640 1.4× 116 0.5× 232 1.6× 46 1.6k
Siva Kanangat United States 18 701 0.9× 968 1.8× 133 0.3× 129 0.5× 151 1.0× 26 1.8k
Juan Moyron‐Quiroz United States 10 460 0.6× 1.2k 2.1× 176 0.4× 133 0.5× 230 1.5× 12 1.6k
Malcolm P. France Australia 9 679 0.9× 621 1.1× 829 1.9× 65 0.3× 163 1.1× 11 1.6k
Aruna K. Behera United States 20 380 0.5× 351 0.6× 317 0.7× 269 1.0× 52 0.3× 27 1.2k
Morihiro Ito Japan 24 727 1.0× 250 0.5× 432 1.0× 102 0.4× 110 0.7× 88 1.4k
Aalzen de Haan Netherlands 25 753 1.0× 770 1.4× 380 0.9× 197 0.8× 90 0.6× 66 1.9k
S Montplaisir Canada 22 428 0.6× 347 0.6× 376 0.8× 105 0.4× 106 0.7× 78 1.2k
Mónica G. Chiaramonte United States 18 515 0.7× 711 1.3× 110 0.2× 263 1.0× 140 0.9× 29 2.0k

Countries citing papers authored by Gerald E. Hancock

Since Specialization
Citations

This map shows the geographic impact of Gerald E. Hancock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald E. Hancock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald E. Hancock more than expected).

Fields of papers citing papers by Gerald E. Hancock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald E. Hancock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald E. Hancock. The network helps show where Gerald E. Hancock may publish in the future.

Co-authorship network of co-authors of Gerald E. Hancock

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald E. Hancock. A scholar is included among the top collaborators of Gerald E. Hancock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald E. Hancock. Gerald E. Hancock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Faoagali, Joan, et al.. (2014). Efficacy of some colloidal silver preparations and silver salts against Proteus bacteria, one possible cause of rheumatoid arthritis. Inflammopharmacology. 22(2). 73–77. 9 indexed citations
2.
4.
Tebbey, Paul W., et al.. (2004). Inhibition of respiratory syncytial virus infection with the CC chemokine RANTES (CCL5). Journal of Medical Virology. 73(2). 300–308. 25 indexed citations
7.
Hancock, Gerald E., et al.. (2001). Adaptive Immune Responses of Patients with Asthma to the Attachment (G) Glycoprotein of Respiratory Syncytial Virus. The Journal of Infectious Diseases. 184(12). 1589–1593. 11 indexed citations
9.
Hancock, Gerald E., et al.. (2000). QS-21 Synergizes with Recombinant Interleukin-12 to Create a Potent Adjuvant Formulation for the Fusion Protein of Respiratory Syncytial Virus. Viral Immunology. 13(4). 503–509. 11 indexed citations
10.
Hancock, Gerald E., et al.. (2000). Serum Neutralizing Antibody Titers of Seropositive Chimpanzees Immunized with Vaccines Coformulated with Natural Fusion and Attachment Proteins of Respiratory Syncytial Virus. The Journal of Infectious Diseases. 181(5). 1768–1771. 22 indexed citations
11.
Tebbey, Paul W., et al.. (1999). A Novel and Effective Intranasal Immunization Strategy for Respiratory Syncytial Virus. Viral Immunology. 12(1). 41–45. 13 indexed citations
12.
Tebbey, Paul W., Michael Hagen, & Gerald E. Hancock. (1998). Atypical Pulmonary Eosinophilia Is Mediated by a Specific Amino Acid Sequence of the Attachment (G) Protein of Respiratory Syncytial Virus. The Journal of Experimental Medicine. 188(10). 1967–1972. 117 indexed citations
14.
Hancock, Gerald E., et al.. (1994). The pulmonary immune response of Balb/c mice vaccinated with the fusion protein of respiratory syncytial virus. Vaccine. 12(3). 267–274. 20 indexed citations
15.
Kaplan, Gilla, Warwick J. Britton, Gerald E. Hancock, et al.. (1991). The systemic influence of recombinant interleukin 2 on the manifestations of lepromatous leprosy.. The Journal of Experimental Medicine. 173(4). 993–1006. 67 indexed citations
16.
Hancock, Gerald E., Anthony G. Molloy, Abhijit Kale, et al.. (1991). In vivo administration of low-dose human interleukin-2 induces lymphokine-activated killer cells for enhanced cytolysis in vitro. Cellular Immunology. 132(2). 277–284. 12 indexed citations
17.
Converse, Paul J., Tom H. M. Ottenhoff, Gerald E. Hancock, et al.. (1990). Intradermal Recombinant Interleukin 2 Enhances Peripheral Blood T‐Cell Responses to Mitogen and Antigens in Patients with Lepromatous Leprosy. Scandinavian Journal of Immunology. 32(2). 83–91. 17 indexed citations
18.
Kaplan, Gilla, Rolf Kiessling, Gerald E. Hancock, et al.. (1989). The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin 2.. The Journal of Experimental Medicine. 169(3). 893–907. 84 indexed citations
19.
Hancock, Gerald E., Gilla Kaplan, & Zanvil A. Cohn. (1988). Keratinocyte growth regulation by the products of immune cells.. The Journal of Experimental Medicine. 168(4). 1395–1402. 152 indexed citations
20.
Kaplan, Gilla, Andrew D. Luster, Gerald E. Hancock, & Zanvil A. Cohn. (1987). The expression of a gamma interferon-induced protein (IP-10) in delayed immune responses in human skin.. The Journal of Experimental Medicine. 166(4). 1098–1108. 237 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026